We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
Amcor
AMCR
$22.4B
| $499K | ﹤0.01% |
11,507
+4,611
| +67% | +$183K |
2025 Q4
2 quarters
|
|
2427
Byline Bancorp
BY
$1.76B
| $497K | ﹤0.01% |
13,206
-1,442
| -10% | -$48.5K |
2026 Q1
1 quarter
|
|
2428
PUT
CleanSpark
CLSK
$1.92B
| $495K | ﹤0.01% |
34,000
-655,700
| -95% | -$9.25M |
2025 Q4
2 quarters
|
|
2429
PUT
AngloGold Ashanti
AU
$42B
| $493K | ﹤0.01% |
+6,100
| New | +$579K |
2026 Q2
0 quarters
|
|
2430
Ellington Financial
EFC
$1.49B
| $493K | ﹤0.01% |
36,237
-108,168
| -75% | -$1.43M |
2025 Q4
2 quarters
|
|
2431
Canadian Natural Resources
CNQ
$111B
| $489K | ﹤0.01% |
12,364
-12,013
| -49% | -$546K |
2022 Q2
16 quarters
|
|
2432
Jazz Pharmaceuticals
JAZZ
$13.9B
| $487K | ﹤0.01% |
+2,023
| New | +$443K |
2026 Q2
0 quarters
|
|
2433
CF Industries
CF
$18.3B
| $487K | ﹤0.01% |
4,501
+2,073
| +85% | +$244K |
2025 Q4
2 quarters
|
|
2434
CALL
Accenture
ACN
$160B
| $485K | ﹤0.01% |
3,900
-12,400
| -76% | -$2.15M |
2026 Q1
1 quarter
|
|
2435
LyondellBasell Industries
LYB
$21.7B
| $485K | ﹤0.01% |
9,205
+4,982
| +118% | +$344K |
2026 Q1
1 quarter
|
|
2436
Southern Copper
SCCO
$155B
| $483K | ﹤0.01% |
+2,803
| New | +$504K |
2026 Q2
0 quarters
|
|
2437
Enova International
ENVA
$4.32B
| $482K | ﹤0.01% |
2,004
+455
| +29% | +$78.3K |
2026 Q1
1 quarter
|
|
2438
Strata Critical Medical Inc
SRTA
$391M
| $482K | ﹤0.01% |
+91,533
| New | +$482K |
2026 Q2
0 quarters
|
|
2439
Spire Global
SPIR
$339M
| $482K | ﹤0.01% |
+25,889
| New | +$481K |
2026 Q2
0 quarters
|
|
2440
LATAM Airlines Group S.A.
LTM
$12.8B
| $481K | ﹤0.01% |
8,263
+1,611
| +24% | +$82.9K |
2025 Q2
4 quarters
|
|
2441
Malibu Boats
MBUU
$493M
| $481K | ﹤0.01% |
17,535
-8,991
| -34% | -$239K |
2025 Q3
3 quarters
|
|
2442
Talen Energy Corp
TLN
$15.9B
| $477K | ﹤0.01% |
1,242
+58
| +5% | +$21.3K |
2024 Q3
7 quarters
|
|
2443
Aveanna Healthcare
AVAH
$2.86B
| $476K | ﹤0.01% |
55,561
-11,006
| -17% | -$77.6K |
2025 Q4
2 quarters
|
|
2444
Innventure Inc
INV
$27.4M
| $475K | ﹤0.01% |
93,777
-1,055,802
| -92% | -$6.21M |
2026 Q1
1 quarter
|
|
2445
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.88B
| $475K | ﹤0.01% |
+9,390
| New | +$453K |
2026 Q2
0 quarters
|
|
2446
Columbus McKinnon
CMCO
$470M
| $475K | ﹤0.01% |
31,379
+20,230
| +181% | +$301K |
2025 Q4
2 quarters
|
|
2447
CALL
BioNTech
BNTX
$22B
| $475K | ﹤0.01% |
5,100
-8,100
| -61% | -$762K |
2025 Q4
2 quarters
|
|
2448
TripAdvisor
TRIP
$1.13B
| $473K | ﹤0.01% |
+34,501
| New | +$390K |
2026 Q2
0 quarters
|
|
2449
CRA International
CRAI
$1.24B
| $473K | ﹤0.01% |
+3,324
| New | +$500K |
2026 Q2
0 quarters
|
|
2450
EVgo
EVGO
$269M
| $473K | ﹤0.01% |
247,639
+92,647
| +60% | +$187K |
2025 Q4
2 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.